Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2008, Article ID 524601, 4 pages
Research Article

High Rate of Severe Fetal Outcomes Associated with Maternal Parvovirus B19 Infection in Pregnancy

1Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
2Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN 55455, USA

Received 22 August 2007; Accepted 15 February 2008

Academic Editor: Sebastian Faro

Copyright © 2008 Richard H. Beigi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Levy, A. Weissman, G. Blomberg, and Z. J. Hagay, “Infection by parvovirus B19 during pregnancy: a review,” Obstetrical & Gynecological Survey, vol. 52, no. 4, pp. 254–259, 1997. View at Google Scholar
  2. I. P. Jensen, O. Schou, and B. F. Vestergaard, “The 1994 human parvovirus B19 epidemic in Denmark: diagnostic and epidemiological experience,” APMIS, vol. 106, no. 9, pp. 843–848, 1998. View at Google Scholar
  3. A. K. Valeur-Jensen, C. B. Pedersen, T. Westergaard et al., “Risk factors for parvovirus B19 infection in pregnancy,” The Journal of the American Medical Association, vol. 281, no. 12, pp. 1099–1105, 1999. View at Publisher · View at Google Scholar
  4. F. Forestier, J.-D. Tissot, Y. Vial, F. Daffos, and P. Hohlfeld, “Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis,” British Journal of Haematology, vol. 104, no. 4, pp. 925–927, 1999. View at Publisher · View at Google Scholar
  5. J. F. Rodis, A. F. Borgida, M. Wilson et al., “Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the society of perinatal obstetricians,” American Journal of Obstetrics and Gynecology, vol. 179, no. 4, pp. 985–988, 1998. View at Publisher · View at Google Scholar
  6. J. H. Harger, S. P. Adler, W. C. Koch, and G. F. Harger, “Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms,” Obstetrics & Gynecology, vol. 91, no. 3, pp. 413–420, 1998. View at Publisher · View at Google Scholar
  7. T. Tolfvenstam, N. Papadogiannakis, O. Norbeck, K. Petersson, and K. Broliden, “Frequency of human parvovirus B19 infection in intrauterine fetal death,” The Lancet, vol. 357, no. 9267, pp. 1494–1497, 2001. View at Publisher · View at Google Scholar
  8. W. R. Ballou, J. L. Reed, W. Noble, N. S. Young, and S. Koenig, “Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1,” The Journal of Infectious Diseases, vol. 187, no. 4, pp. 675–678, 2003. View at Publisher · View at Google Scholar